Across TCGA pan-cancer cohorts, LINC02523 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02523’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC02523 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02523 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

THCA and LUAD are the cancer types where LINC02523 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02523 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	+0.027	.001	4	view →
LUAD	Female	III,IV	−0.033	.005	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC02523 RNA expression & survival · all LINC02523 data types